ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/11 | 1,431 | 1,443 | 1,425 | 1,430 | -13 | -0.9% | 268,400 |
| 2023/05/10 | 1,462 | 1,462 | 1,435 | 1,443 | -15 | -1% | 206,000 |
| 2023/05/09 | 1,426 | 1,463 | 1,415 | 1,458 | +24 | +1.7% | 295,800 |
| 2023/05/08 | 1,453 | 1,457 | 1,425 | 1,434 | -25 | -1.7% | 224,600 |
| 2023/05/02 | 1,473 | 1,484 | 1,445 | 1,459 | +8 | +0.6% | 298,400 |
| 2023/05/01 | 1,465 | 1,480 | 1,437 | 1,451 | -12 | -0.8% | 221,900 |
| 2023/04/28 | 1,456 | 1,473 | 1,440 | 1,463 | +33 | +2.3% | 266,700 |
| 2023/04/27 | 1,428 | 1,445 | 1,423 | 1,430 | -13 | -0.9% | 305,200 |
| 2023/04/26 | 1,460 | 1,485 | 1,439 | 1,443 | -31 | -2.1% | 247,600 |
| 2023/04/25 | 1,466 | 1,488 | 1,465 | 1,474 | +1 | +0.1% | 151,700 |
| 2023/04/24 | 1,474 | 1,485 | 1,465 | 1,473 | +10 | +0.7% | 153,300 |
| 2023/04/21 | 1,466 | 1,466 | 1,438 | 1,463 | -4 | -0.3% | 214,900 |
| 2023/04/20 | 1,482 | 1,483 | 1,465 | 1,467 | -23 | -1.5% | 286,500 |
| 2023/04/19 | 1,481 | 1,499 | 1,476 | 1,490 | -19 | -1.3% | 247,200 |
| 2023/04/18 | 1,505 | 1,514 | 1,494 | 1,509 | +22 | +1.5% | 204,200 |
| 2023/04/17 | 1,501 | 1,505 | 1,473 | 1,487 | -25 | -1.7% | 253,900 |
| 2023/04/14 | 1,497 | 1,521 | 1,495 | 1,512 | +61 | +4.2% | 457,700 |
| 2023/04/13 | 1,452 | 1,476 | 1,446 | 1,451 | -12 | -0.8% | 283,000 |
| 2023/04/12 | 1,490 | 1,497 | 1,460 | 1,463 | -23 | -1.5% | 275,800 |
| 2023/04/11 | 1,478 | 1,503 | 1,477 | 1,486 | +26 | +1.8% | 341,800 |
| 2023/04/10 | 1,447 | 1,467 | 1,441 | 1,460 | +1 | +0.1% | 264,700 |
| 2023/04/07 | 1,465 | 1,473 | 1,450 | 1,459 | +18 | +1.2% | 384,400 |
| 2023/04/06 | 1,390 | 1,444 | 1,385 | 1,441 | +44 | +3.1% | 547,200 |
| 2023/04/05 | 1,428 | 1,442 | 1,395 | 1,397 | -37 | -2.6% | 470,200 |
| 2023/04/04 | 1,431 | 1,454 | 1,410 | 1,434 | +3 | +0.2% | 498,000 |
| 2023/04/03 | 1,409 | 1,460 | 1,408 | 1,431 | +18 | +1.3% | 655,900 |
| 2023/03/31 | 1,496 | 1,501 | 1,407 | 1,413 | -119 | -7.8% | 1,203,200 |
| 2023/03/30 | 1,537 | 1,549 | 1,520 | 1,532 | -12 | -0.8% | 226,700 |
| 2023/03/29 | 1,534 | 1,563 | 1,525 | 1,544 | +20 | +1.3% | 368,400 |
| 2023/03/28 | 1,534 | 1,538 | 1,495 | 1,524 | -19 | -1.2% | 218,000 |
| 2023/03/27 | 1,538 | 1,546 | 1,516 | 1,543 | +13 | +0.8% | 305,000 |
| 2023/03/24 | 1,520 | 1,537 | 1,489 | 1,530 | +10 | +0.7% | 356,800 |
| 2023/03/23 | 1,478 | 1,526 | 1,465 | 1,520 | +29 | +1.9% | 424,800 |
| 2023/03/22 | 1,504 | 1,506 | 1,475 | 1,491 | +15 | +1% | 208,200 |
| 2023/03/20 | 1,503 | 1,505 | 1,475 | 1,476 | -29 | -1.9% | 277,300 |
| 2023/03/17 | 1,460 | 1,508 | 1,460 | 1,505 | +62 | +4.3% | 342,900 |
| 2023/03/16 | 1,436 | 1,451 | 1,414 | 1,443 | -19 | -1.3% | 232,300 |
| 2023/03/15 | 1,477 | 1,483 | 1,454 | 1,462 | -17 | -1.1% | 216,100 |
| 2023/03/14 | 1,484 | 1,494 | 1,453 | 1,479 | -26 | -1.7% | 300,200 |
| 2023/03/13 | 1,487 | 1,515 | 1,481 | 1,505 | -22 | -1.4% | 261,100 |
| 2023/03/10 | 1,582 | 1,589 | 1,527 | 1,527 | -79 | -4.9% | 496,600 |
| 2023/03/09 | 1,550 | 1,652 | 1,547 | 1,606 | +89 | +5.9% | 957,900 |
| 2023/03/08 | 1,492 | 1,525 | 1,486 | 1,517 | +33 | +2.2% | 428,500 |
| 2023/03/07 | 1,487 | 1,502 | 1,475 | 1,484 | +5 | +0.3% | 345,500 |
| 2023/03/06 | 1,477 | 1,488 | 1,466 | 1,479 | -6 | -0.4% | 351,000 |
| 2023/03/03 | 1,460 | 1,488 | 1,445 | 1,485 | +37 | +2.6% | 416,700 |
| 2023/03/02 | 1,413 | 1,448 | 1,405 | 1,448 | +25 | +1.8% | 422,600 |
| 2023/03/01 | 1,470 | 1,473 | 1,404 | 1,423 | -45 | -3.1% | 560,100 |
| 2023/02/28 | 1,475 | 1,483 | 1,445 | 1,468 | +19 | +1.3% | 419,400 |
| 2023/02/27 | 1,459 | 1,465 | 1,433 | 1,449 | -36 | -2.4% | 390,400 |
251～
300
件表示中 / 6711件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,200円 | -3.7% | -36.7% | 3.22% | 20.98倍 | 1.40倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ゼリア新薬 | 200,900円 | +9.6% | +17.5% | 2.29% | 11.35倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 214,700円 | +7.6% | +57.5% | 2.47% | 16.58倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 227,700円 | +0.3% | +2.7% | 2.20% | 12.90倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| 生化学 | 78,400円 | +10.5% | +169.1% | 3.83% | 12.40倍 | 0.59倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
市場注目の銘柄
チャート関連のコラム
